Notably, this includes the downregulation of lncRNA ZNF582-AS1 and lncRNA APCDD1L-AS1, both of which exert regulatory control over the progression of ccRCC [40, 41]. This evidence concerns the gene APCDD1L and nonpapillary renal cell carcinoma.